Original Source(s)
Related Content
Commentary: The long-term psychological processing of an autism spectrum disorder diagnosis in parents
July 3, 2026
FDA Expands Pediatric Roflumilast Use
The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.
June 30, 2026
-
3 min